Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer
The present study aimed to examine the polymorphism -938C > A of BCL-2 gene and promoter -248G>A in the Bax gene, as well as their relationship with specific clinical-pathological characteristics, in patients with breast cancer. Blood samples were obtained from 70 patients who had been diagnos...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Razi Vaccine and Serum Research Institute
2022-04-01
|
| Series: | Archives of Razi Institute |
| Subjects: | |
| Online Access: | https://archrazi.areeo.ac.ir/article_125750_14ab9359f8d50c2dcbc0e89b16c8bad3.pdf |
| _version_ | 1818117268616249344 |
|---|---|
| author | H. F. S Al-Zubaidy S. R Majeed D. A. F Al-Koofee |
| author_facet | H. F. S Al-Zubaidy S. R Majeed D. A. F Al-Koofee |
| author_sort | H. F. S Al-Zubaidy |
| collection | DOAJ |
| description | The present study aimed to examine the polymorphism -938C > A of BCL-2 gene and promoter -248G>A in the Bax gene, as well as their relationship with specific clinical-pathological characteristics, in patients with breast cancer. Blood samples were obtained from 70 patients who had been diagnosed with breast cancer and 34 healthy women as the control group. Polymorphic analysis was performed using the polymerase chain reaction-restriction fragment length polymorphism assay. Anthropometric data were assessed. Estrogen receptor (ER), human epidermal growth factor receptor 2 (Her-2), and progesterone receptor (PR) were measured by immunohistochemistry. The data of age and body mass index (BMI) demonstrated no significant variations between the two groups (P>0.05). The results of HER-2 revealed that 42.86% of breast cancer patients reflected positively for Her-2/neu expression, while 24.29% reflected negative results of Her-2/neu. Moreover, the results of ER revealed that 42.86% and 28.57% of subjects were positive and negative ER, respectively; moreover, the missing data was 28.57%. In addition, the results of PR indicated that 35.71% of patients (25/70) were positive for PR, while 28.57% reflected negative results, and the missing results were 35.71%. The genotype and allele frequencies of BCL-2(-938C>A) were not statistically significant in women with breast cancer and the control group (P=0.574, P=0.533) for heterozygous and recessive models, respectively. The genotype of BCL-2(-938C>A) in control and patients in codominant, dominant, recessive, and additive models demonstrated no significant variations of all genotypes in all groups. Genotypes and allele frequencies for Bax (-248G>A) in patients with breast cancer and control indicated that the frequencies of GG, AG, and AA genotypes in cases were 16.67%, 3.33%, and 80 %, while in controls, these values were 3.23 %, 58.06 %, and 3.23 %, respectively. The heterozygous genotype (AG) in the codominant model was OR=36.00 (95% CI: 4.5608 - 284.1608; P=0.0007). In comparison with the wild type (GG), there was a 36-fold increase in the risk of breast cancer. Furthermore, the findings of this study revealed a significant correlation between Bax (-248G>A) polymorphism and breast cancer risk under the dominant and overdominant (OR=6.33; 95% CI: 2.2604 -17.7452; P=0.0004, and OR=40.154; 95% CI: 5.1365 - 313.8949; P=0.0004, respectively. The recessive model revealed that there was a decreased risk of breast cancer (OR= 0.167; 95% CI: 0.0303 to 0.9168; P=0.039). Based on the results, it can be concluded that there were no significant variations in BCL-2 (-938C>A) polymorphism of all genotypes models when breast cancer women are compared with healthy ones. In a similar vein, there was no significant association between the BCL-2 (-938C>A) polymorphism and breast cancer risk under dominant, codominant, or recessive models. |
| first_indexed | 2024-12-11T04:35:43Z |
| format | Article |
| id | doaj.art-dd20a2299daf446693b70dda43f40ff6 |
| institution | Directory Open Access Journal |
| issn | 0365-3439 2008-9872 |
| language | English |
| last_indexed | 2024-12-11T04:35:43Z |
| publishDate | 2022-04-01 |
| publisher | Razi Vaccine and Serum Research Institute |
| record_format | Article |
| series | Archives of Razi Institute |
| spelling | doaj.art-dd20a2299daf446693b70dda43f40ff62022-12-22T01:20:45ZengRazi Vaccine and Serum Research InstituteArchives of Razi Institute0365-34392008-98722022-04-0177279980810.22092/ari.2022.357090.1968125750Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast CancerH. F. S Al-Zubaidy0S. R Majeed1D. A. F Al-Koofee2Faculty of Pharmacy, University of Kufa, Kufa, IraqFaculty of Pharmacy, University of Kufa, Kufa, IraqFaculty of Pharmacy, University of Kufa, Kufa, IraqThe present study aimed to examine the polymorphism -938C > A of BCL-2 gene and promoter -248G>A in the Bax gene, as well as their relationship with specific clinical-pathological characteristics, in patients with breast cancer. Blood samples were obtained from 70 patients who had been diagnosed with breast cancer and 34 healthy women as the control group. Polymorphic analysis was performed using the polymerase chain reaction-restriction fragment length polymorphism assay. Anthropometric data were assessed. Estrogen receptor (ER), human epidermal growth factor receptor 2 (Her-2), and progesterone receptor (PR) were measured by immunohistochemistry. The data of age and body mass index (BMI) demonstrated no significant variations between the two groups (P>0.05). The results of HER-2 revealed that 42.86% of breast cancer patients reflected positively for Her-2/neu expression, while 24.29% reflected negative results of Her-2/neu. Moreover, the results of ER revealed that 42.86% and 28.57% of subjects were positive and negative ER, respectively; moreover, the missing data was 28.57%. In addition, the results of PR indicated that 35.71% of patients (25/70) were positive for PR, while 28.57% reflected negative results, and the missing results were 35.71%. The genotype and allele frequencies of BCL-2(-938C>A) were not statistically significant in women with breast cancer and the control group (P=0.574, P=0.533) for heterozygous and recessive models, respectively. The genotype of BCL-2(-938C>A) in control and patients in codominant, dominant, recessive, and additive models demonstrated no significant variations of all genotypes in all groups. Genotypes and allele frequencies for Bax (-248G>A) in patients with breast cancer and control indicated that the frequencies of GG, AG, and AA genotypes in cases were 16.67%, 3.33%, and 80 %, while in controls, these values were 3.23 %, 58.06 %, and 3.23 %, respectively. The heterozygous genotype (AG) in the codominant model was OR=36.00 (95% CI: 4.5608 - 284.1608; P=0.0007). In comparison with the wild type (GG), there was a 36-fold increase in the risk of breast cancer. Furthermore, the findings of this study revealed a significant correlation between Bax (-248G>A) polymorphism and breast cancer risk under the dominant and overdominant (OR=6.33; 95% CI: 2.2604 -17.7452; P=0.0004, and OR=40.154; 95% CI: 5.1365 - 313.8949; P=0.0004, respectively. The recessive model revealed that there was a decreased risk of breast cancer (OR= 0.167; 95% CI: 0.0303 to 0.9168; P=0.039). Based on the results, it can be concluded that there were no significant variations in BCL-2 (-938C>A) polymorphism of all genotypes models when breast cancer women are compared with healthy ones. In a similar vein, there was no significant association between the BCL-2 (-938C>A) polymorphism and breast cancer risk under dominant, codominant, or recessive models.https://archrazi.areeo.ac.ir/article_125750_14ab9359f8d50c2dcbc0e89b16c8bad3.pdfbax genebcl-2 genebreast cancer248g>a polymorphism-938c > -97h526a polymorphismiraq |
| spellingShingle | H. F. S Al-Zubaidy S. R Majeed D. A. F Al-Koofee Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer Archives of Razi Institute bax gene bcl-2 gene breast cancer 248g>a polymorphism -938c > -97h526a polymorphism iraq |
| title | Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer |
| title_full | Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer |
| title_fullStr | Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer |
| title_full_unstemmed | Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer |
| title_short | Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer |
| title_sort | evaluation of bax and bcl 2 genes polymorphisms in iraqi women with breast cancer |
| topic | bax gene bcl-2 gene breast cancer 248g>a polymorphism -938c > -97h526a polymorphism iraq |
| url | https://archrazi.areeo.ac.ir/article_125750_14ab9359f8d50c2dcbc0e89b16c8bad3.pdf |
| work_keys_str_mv | AT hfsalzubaidy evaluationofbaxandbcl2genespolymorphismsiniraqiwomenwithbreastcancer AT srmajeed evaluationofbaxandbcl2genespolymorphismsiniraqiwomenwithbreastcancer AT dafalkoofee evaluationofbaxandbcl2genespolymorphismsiniraqiwomenwithbreastcancer |